NCT05031208

Brief Summary

Refractory epilepsy patients implanted with a vagus nerve stimulator perform a memory test at baseline in three conditions: invasive vagus nerve stimulation (VNS), transcutaneous vagus nerve stimulation (taVNS) and sham stimulation. After 6 weeks of VNS treatment, the memory test is repeated in two condition: invasive vagus nerve stimulation (VNS) and sham stimulation. The endpoint of this experiment is assessing the effect of VNS and taVNS on memory performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2020

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 1, 2021

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

1.8 years

First QC Date

August 19, 2021

Last Update Submit

May 2, 2023

Conditions

Keywords

Vagus nerve stimulationTranscutaneous vagus nerve stimulationWord recognition paradigm

Outcome Measures

Primary Outcomes (4)

  • Immediate recall score at session 1

    Free recall score for correctly recalled words (min score 0,max score 21, higher score indicates better performance), calculated as a percentage

    At baseline

  • Immediate recall score at session 2

    Free recall score for correctly recalled words (min score 0, max score 21, higher score indicates better performance)), calculated as a percentage

    After 6 weeks of VNS treatment

  • Delayed recognition scores at session 1

    Hitscore for correctly recognized target words (min score 0,max score 63, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 63, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 63, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 63, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 63, higher score indicates better performance). All scores are calculated as a percentage.

    At baseline

  • Delayed recognition scores at session 2

    Hitscore for correctly recognized target words (min score 0,max score 48, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 48, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 48, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 48, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 48, higher score indicates better performance). All scores are calculated as a percentage.

    After 6 weeks of VNS treatment

Secondary Outcomes (2)

  • Attention score at session 1

    At baseline

  • Attention score at session 2

    After 6 weeks of VNS treatment

Study Arms (3)

Vagus nerve stimulation

EXPERIMENTAL

Invasive vagus nerve stimulation

Diagnostic Test: Memory task

Transcutaneous vagus nerve stimulation

EXPERIMENTAL

Cymba concha stimulation

Diagnostic Test: Memory task

Sham vagus nerve stimulation

SHAM COMPARATOR

No vagus nerve stimulation

Diagnostic Test: Memory task

Interventions

Memory taskDIAGNOSTIC_TEST

Word recognition task

Sham vagus nerve stimulationTranscutaneous vagus nerve stimulationVagus nerve stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Refractory epilepsy
  • Treated with vagus nerve stimulation
  • IQ \>= 70 and able to perform the memory task

You may not qualify if:

  • IQ \< 70

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Ghent, 9000, Belgium

Location

Related Publications (5)

  • Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci. 1999 Jan;2(1):94-8. doi: 10.1038/4600.

    PMID: 10195186BACKGROUND
  • Jacobs HI, Riphagen JM, Razat CM, Wiese S, Sack AT. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol Aging. 2015 May;36(5):1860-7. doi: 10.1016/j.neurobiolaging.2015.02.023. Epub 2015 Feb 28.

    PMID: 25805212BACKGROUND
  • Colzato LS, Ritter SM, Steenbergen L. Transcutaneous vagus nerve stimulation (tVNS) enhances divergent thinking. Neuropsychologia. 2018 Mar;111:72-76. doi: 10.1016/j.neuropsychologia.2018.01.003. Epub 2018 Jan 8.

    PMID: 29326067BACKGROUND
  • Steenbergen L, Sellaro R, Stock AK, Verkuil B, Beste C, Colzato LS. RETRACTED: Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during action cascading processes. Eur Neuropsychopharmacol. 2015 Jun;25(6):773-8. doi: 10.1016/j.euroneuro.2015.03.015. Epub 2015 Mar 30.

    PMID: 25869158BACKGROUND
  • Mertens A, Gadeyne S, Lescrauwaet E, Carrette E, Meurs A, De Herdt V, Dewaele F, Raedt R, Miatton M, Boon P, Vonck K. The potential of invasive and non-invasive vagus nerve stimulation to improve verbal memory performance in epilepsy patients. Sci Rep. 2022 Feb 7;12(1):1984. doi: 10.1038/s41598-022-05842-3.

MeSH Terms

Conditions

Drug Resistant Epilepsy

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2021

First Posted

September 1, 2021

Study Start

November 22, 2018

Primary Completion

August 28, 2020

Study Completion

August 28, 2020

Last Updated

May 6, 2023

Record last verified: 2023-05

Locations